Concepedia

Author

Ann-Louise Hagbjörk

Karolinska Institutet

Also Known As

A.- L. Hagbjork, A.L. Hagbjörk, Ann-Louise Hagbjörk

8

Publications

478

Citations

6

H-Index

39

Concepts

All Affiliations

Karolinska InstitutetHarbor–UCLA Medical CenterUCLA Medical CenterMedivir (Sweden)
AH

About

Ann-Louise Hagbjörk is an author at Karolinska Institutet specializing in pharmacology, medicine, and biochemistry.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

464

2

Biochemistry

5

5

464

3

Health Sciences

2

2

345

4

Natural Sciences

2

2

99

5

Cellular Physiology

1

1

52

Ann-Louise Hagbjörk

×

6

Publications

475

Citations

6

H-Index

YearCitations

Fish Oil, Alcohol, and Liver Pathology: Role of Cytochrome P450 2E1

M Morimoto, Mark Α. Zern, Ann-Louise Hagbjörk,

Experimental Biology and Medicine

1994

179

Modulation of experimental alcohol-induced liver disease by cytochrome P450 2E1 inhibitors

Michio Morimoto, Ann-Louise Hagbjörk, Yu‐Jui Yvonne Wan,

Hepatology

1995

166

High Rates of Substrate Hydroxylation by Human Cytochrome P450 3A4 in Reconstituted Membranous Vesicles: Influence of Membrane Charge

Magnus Ingelman‐Sundberg, Ann-Louise Hagbjörk, Yune‐Fang Ueng,

Biochemical and Biophysical Research Communications

1996

52

Discovery of the First Potent and Selective Inhibitors of Human dCTP Pyrophosphatase 1

Sabin Llona‐Minguez, Andreas Höglund, Sylvain A. Jacques,

Journal of Medicinal Chemistry

2016

47

Gas chromatographic–mass spectrometry method for the detection of busulphan and its metabolites in plasma and urine

Ibrahim El‐Serafi, Ylva Terelius, Brigitte Twelkmeyer,

Journal of Chromatography B

2012

20

A strategy for early-risk predictions of clinical drug–drug interactions involving the GastroPlus<sup>TM</sup> DDI module for time-dependent CYP inhibitors

Anna-Karin Sohlenius-Sternbeck, Gabrielle Meyerson, Ann-Louise Hagbjörk,

Xenobiotica

2017

11

Page 1